Inhaled nitric oxide for treating pain crises in people with sickle cell disease

Abdulkareem Altawashi, Omar Albaroudi, Tarek Aboursheid, Fares Alahdab

Research output: Contribution to journalArticlepeer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To capture the available body of evidence that evaluates the efficacy and safety of the use of iNO in treating pain crises in people with SCD; and to assess the treatment's relevance, robustness, and validity, in order to better guide medical practice in the fields of haematology and palliative care (since recent literature seems to favour the involvement of palliative care for those people).

Original languageEnglish (US)
Article numberCD011808
JournalCochrane Database of Systematic Reviews
Volume2015
Issue number7
DOIs
StatePublished - Jul 22 2015

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Inhaled nitric oxide for treating pain crises in people with sickle cell disease'. Together they form a unique fingerprint.

Cite this